Amibegron - sanofi-aventis
Alternative Names: SR 58611; SR 58611ALatest Information Update: 24 Oct 2021
At a glance
- Originator sanofi-aventis
- Class Acetic acids; Amines; Antidepressants; Carboxylic acids; Chlorobenzenes; Esters; Naphthalenes; Small molecules
- Mechanism of Action Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Generalised anxiety disorder; Irritable bowel syndrome; Major depressive disorder; Obesity
Most Recent Events
- 31 Jul 2008 Discontinued - Phase-III for Depression in Argentina (unspecified route)
- 31 Jul 2008 Discontinued - Phase-III for Depression in Asia (unspecified route)
- 31 Jul 2008 Discontinued - Phase-III for Depression in Croatia (unspecified route)